Cargando…

Informing selection of drugs for COVID-19 treatment through adverse events analysis

Coronavirus disease 2019 (COVID-19) is an ongoing pandemic and there is an urgent need for safe and effective drugs for COVID-19 treatment. Since developing a new drug is time consuming, many approved or investigational drugs have been repurposed for COVID-19 treatment in clinical trials. Therefore,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Wenjing, Pan, Bohu, Sakkiah, Sugunadevi, Ji, Zuowei, Yavas, Gokhan, Lu, Yanhui, Komatsu, Takashi E., Lal-Nag, Madhu, Tong, Weida, Patterson, Tucker A., Hong, Huixiao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8263777/ https://www.ncbi.nlm.nih.gov/pubmed/34234253 http://dx.doi.org/10.1038/s41598-021-93500-5

Ejemplares similares

Elucidating Interactions Between SARS-CoV-2 Trimeric Spike Protein and ACE2 Using Homology Modeling and Molecular Dynamics Simulations
por: Sakkiah, Sugunadevi, et al.
Publicado: (2021)

Persistent Organic Pollutants in Food: Contamination Sources, Health Effects and Detection Methods
por: Guo, Wenjing, et al.
Publicado: (2019)

Identification of Epidemiological Traits by Analysis of SARS−CoV−2 Sequences
por: Pan, Bohu, et al.
Publicado: (2021)

Structural Changes Due to Antagonist Binding in Ligand Binding Pocket of Androgen Receptor Elucidated Through Molecular Dynamics Simulations
por: Sakkiah, Sugunadevi, et al.
Publicado: (2018)

Endocrine Disrupting Chemicals Mediated through Binding Androgen Receptor Are Associated with Diabetes Mellitus
por: Sakkiah, Sugunadevi, et al.
Publicado: (2017)

Nanomaterial Databases: Data Sources for Promoting Design and Risk Assessment of Nanomaterials
por: Ji, Zuowei, et al.
Publicado: (2021)

Competitive docking model for prediction of the human nicotinic acetylcholine receptor α7 binding of tobacco constituents
por: Ng, Hui Wen, et al.
Publicado: (2018)

Consensus Modeling for Prediction of Estrogenic Activity of Ingredients Commonly Used in Sunscreen Products
por: Hong, Huixiao, et al.
Publicado: (2016)

Development of estrogen receptor beta binding prediction model using large sets of chemicals
por: Sakkiah, Sugunadevi, et al.
Publicado: (2017)

Elucidation of Agonist and Antagonist Dynamic Binding Patterns in ER-α by Integration of Molecular Docking, Molecular Dynamics Simulations and Quantum Mechanical Calculations
por: Sakkiah, Sugunadevi, et al.
Publicado: (2021)

Similarities and differences between variants called with human reference genome HG19 or HG38
por: Pan, Bohu, et al.
Publicado: (2019)

Correction to: Similarities and differences between variants called with human reference genome HG19 or HG38
por: Pan, Bohu, et al.
Publicado: (2019)

Pathway Analysis Revealed Potential Diverse Health Impacts of Flavonoids that Bind Estrogen Receptors
por: Ye, Hao, et al.
Publicado: (2016)

A Rat α-Fetoprotein Binding Activity Prediction Model to Facilitate Assessment of the Endocrine Disruption Potential of Environmental Chemicals
por: Hong, Huixiao, et al.
Publicado: (2016)

Direct comparison of performance of single nucleotide variant calling in human genome with alignment-based and assembly-based approaches
por: Wu, Leihong, et al.
Publicado: (2017)

Experimental Data Extraction and in Silico Prediction of the Estrogenic Activity of Renewable Replacements for Bisphenol A
por: Hong, Huixiao, et al.
Publicado: (2016)

sNebula, a network-based algorithm to predict binding between human leukocyte antigens and peptides
por: Luo, Heng, et al.
Publicado: (2016)

dnAQET: a framework to compute a consolidated metric for benchmarking quality of de novo assemblies
por: Yavas, Gokhan, et al.
Publicado: (2019)

Potent bace-1 inhibitor design using pharmacophore modeling, in silico screening and molecular docking studies
por: John, Shalini, et al.
Publicado: (2011)

Insight the C-Site Pocket Conformational Changes Responsible for Sirtuin 2 Activity Using Molecular Dynamics Simulations
por: Sakkiah, Sugunadevi, et al.
Publicado: (2013)

An Innovative Strategy for Dual Inhibitor Design and Its Application in Dual Inhibition of Human Thymidylate Synthase and Dihydrofolate Reductase Enzymes
por: Arooj, Mahreen, et al.
Publicado: (2013)

Editorial: Novel Therapeutic Interventions Against Infectious Diseases: COVID-19
por: Sakkiah, Sugunadevi, et al.
Publicado: (2022)

AI-based language models powering drug discovery and development
por: Liu, Zhichao, et al.
Publicado: (2021)

A Combination of Receptor-Based Pharmacophore Modeling & QM Techniques for Identification of Human Chymase Inhibitors
por: Arooj, Mahreen, et al.
Publicado: (2013)

AI-powered drug repurposing for developing COVID-19 treatments
por: Liu, Zhichao, et al.
Publicado: (2022)

Identification of Important Chemical Features of 11β-Hydroxysteroid Dehydrogenase Type1 Inhibitors: Application of Ligand Based Virtual Screening and Density Functional Theory
por: Sakkiah, Sugunadevi, et al.
Publicado: (2012)

Dynamic and Multi-Pharmacophore Modeling for Designing Polo-Box Domain Inhibitors
por: Sakkiah, Sugunadevi, et al.
Publicado: (2014)

Challenges, Solutions, and Quality Metrics of Personal Genome Assembly in Advancing Precision Medicine
por: Xiao, Wenming, et al.
Publicado: (2016)

Identification of Inhibitor Binding Site in Human Sirtuin 2 Using Molecular Docking and Dynamics Simulations
por: Sakkiah, Sugunadevi, et al.
Publicado: (2013)

Exploration of Virtual Candidates for Human HMG-CoA Reductase Inhibitors Using Pharmacophore Modeling and Molecular Dynamics Simulations
por: Son, Minky, et al.
Publicado: (2013)

Molecular Modeling Study for Inhibition Mechanism of Human Chymase and Its Application in Inhibitor Design
por: Arooj, Mahreen, et al.
Publicado: (2013)

Alignment of Short Reads: A Crucial Step for Application of Next-Generation Sequencing Data in Precision Medicine
por: Ye, Hao, et al.
Publicado: (2015)

Development of Decision Forest Models for Prediction of Drug-Induced Liver Injury in Humans Using A Large Set of FDA-approved Drugs
por: Hong, Huixiao, et al.
Publicado: (2017)

Versatility or Promiscuity: The Estrogen Receptors, Control of Ligand Selectivity and an Update on Subtype Selective Ligands
por: Ng, Hui Wen, et al.
Publicado: (2014)

Machine learning models for rat multigeneration reproductive toxicity prediction
por: Liu, Jie, et al.
Publicado: (2022)

Minimizing Drug Adverse Events by Informing About the Nocebo Effect—An Experimental Study
por: Pan, Yiqi, et al.
Publicado: (2019)

Very Important Pool (VIP) genes – an application for microarray-based molecular signatures
por: Su, Zhenqiang, et al.
Publicado: (2008)

Assessment of Prediction Confidence and Domain Extrapolation of Two Structure–Activity Relationship Models for Predicting Estrogen Receptor Binding Activity
por: Tong, Weida, et al.
Publicado: (2004)

Homology modeling, molecular docking, and molecular dynamics simulations elucidated α-fetoprotein binding modes
por: Shen, Jie, et al.
Publicado: (2013)

Comprehensive Assessments of RNA-seq by the SEQC Consortium: FDA-Led Efforts Advance Precision Medicine
por: Xu, Joshua, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_lcfl36g07antgt817t7ckdl4cl